AnaBios generates predictive human data for clinical trials, reducing time and costs. Using human donor organs and tissues, they study ex-vivo human responses to drugs and investigate relevant physiology. Their research focuses on cardiac disease, pain, PKD kidney disease, and neurodegeneration. They partner with Fortune 500 pharmaceutical companies, CRO's, and universities.